Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Webcast of Its Presentation at the 2014 UBS Global Healthcare Conference

BETHESDA, Md., May 13, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
May 07, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals, Inc., Reports First Quarter 2014 Financial and Operating Results

Strong Financial Performance Driven by Year over Year Income and Revenue Growth Company to host conference call today at 5:00 pm Eastern BETHESDA, Md., May 7, 2014 (GLOBE NEWSWIRE) -- Sucampo...
May 06, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces New Data on AMITIZA and Opioid-Induced Constipation Published Online in Pain Medicine Journal

BETHESDA, Md., May 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, announced that its recent study, "A Randomized Study of...
May 01, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Clinical Data on Lubiprostone to be Presented at Two Upcoming Scientific Conferences

BETHESDA, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...
April 30, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces First Quarter 2014 Results and Operating Highlights Teleconference and Webcast

BETHESDA, Md., April 30, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo"), a global biopharmaceutical company, today announced that it will host a webcast and...
April 25, 2014 16:08 ET | Source: Sucampo Pharmaceuticals Inc

Preclinical Data for Lubiprostone and Unoprostone Isopropyl to be Presented at Experimental Biology Conference 2014

BETHESDA, Md., April 25, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that preclinical data for lubiprostone...
March 25, 2014 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Co-Founder and Chairman Emeritus, Dr. Ryuji Ueno, to Receive Visionary Award From the Foundation Fighting Blindness

BETHESDA, Md., March 25, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the Foundation Fighting Blindness...
March 14, 2014 17:29 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo and Takeda Announce Update on Liquid Formulation Program for AMITIZA(R) (lubiprostone)

BETHESDA, Md., March 14, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharma Americas, LLC, a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), and its development and...
March 12, 2014 20:00 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.

BETHESDA, Md., March 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) today announced that Sucampo Pharma Europe, Ltd., its wholly owned subsidiary, has received a...
March 05, 2014 16:02 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 ROTH Conference

BETHESDA, Md., March 5, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...